Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of α1-adrenoreceptor Antagonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of α1-adrenoreceptor Antagonistsmarket, defines the market attractiveness level of α1-adrenoreceptor Antagonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of α1-adrenoreceptor Antagonists industry, describes the types of α1-adrenoreceptor Antagonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global α1-adrenoreceptor Antagonists market and the development prospects and opportunities of α1-adrenoreceptor Antagonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global α1-adrenoreceptor Antagonists market in Chapter 13.
By Player:
GSK
Bristol-Myers Squibb
Merck
Eli Lilly
Astra Zeneca
Bayer
Novartis
Jhonson and Johnson
Sanofi
Pfizer
Teva Pharmaceutical
By Type:
Non-selective Antagonists
Selective Antagonists
By End-User:
Hypertension
Raynaud's Disease
Erectile Dysfunction
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 α1-adrenoreceptor Antagonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 α1-adrenoreceptor Antagonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 α1-adrenoreceptor Antagonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 α1-adrenoreceptor Antagonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise α1-adrenoreceptor Antagonists Market Analysis and Outlook to 2022
-
7.1 Global α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.2 United States α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.3 Europe α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.4 China α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.5 Japan α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.6 India α1-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.7 South Korea α1-adrenoreceptor Antagonists Consumption (2017-2022)
8 Region and Country-wise α1-adrenoreceptor Antagonists Market Analysis and Outlook to 2028
-
8.1 Global α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.2 United States α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.3 Europe α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.4 China α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.5 Japan α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.6 India α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.7 South Korea α1-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
9 Global α1-adrenoreceptor Antagonists Market Outlook by Types and Applications to 2022
-
9.1 Global α1-adrenoreceptor Antagonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Selective Antagonists Consumption and Growth Rate (2017-2022)
-
9.2 Global α1-adrenoreceptor Antagonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Raynaud's Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
10 Global α1-adrenoreceptor Antagonists Market Outlook by Types and Applications to 2028
-
10.1 Global α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
11 Global α1-adrenoreceptor Antagonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global α1-adrenoreceptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global α1-adrenoreceptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 α1-adrenoreceptor Antagonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global α1-adrenoreceptor Antagonists Market Competitive Analysis
-
14.1 GSK
-
14.1.1 GSK Company Details
-
14.1.2 GSK α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GSK α1-adrenoreceptor Antagonists Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb α1-adrenoreceptor Antagonists Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck α1-adrenoreceptor Antagonists Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly α1-adrenoreceptor Antagonists Product and Service
-
14.5 Astra Zeneca
-
14.5.1 Astra Zeneca Company Details
-
14.5.2 Astra Zeneca α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Astra Zeneca α1-adrenoreceptor Antagonists Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer α1-adrenoreceptor Antagonists Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis α1-adrenoreceptor Antagonists Product and Service
-
14.8 Jhonson and Johnson
-
14.8.1 Jhonson and Johnson Company Details
-
14.8.2 Jhonson and Johnson α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Jhonson and Johnson α1-adrenoreceptor Antagonists Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi α1-adrenoreceptor Antagonists Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer α1-adrenoreceptor Antagonists Product and Service
-
14.11 Teva Pharmaceutical
-
14.11.1 Teva Pharmaceutical Company Details
-
14.11.2 Teva Pharmaceutical α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Teva Pharmaceutical α1-adrenoreceptor Antagonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of α1-adrenoreceptor Antagonists
-
Figure α1-adrenoreceptor Antagonists Picture
-
Table Global α1-adrenoreceptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global α1-adrenoreceptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global α1-adrenoreceptor Antagonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global α1-adrenoreceptor Antagonists Consumption by Country (2017-2022)
-
Figure United States α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Table Europe α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure China α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Japan α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure India α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea α1-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global α1-adrenoreceptor Antagonists Consumption Forecast by Country (2022-2028)
-
Figure United States α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea α1-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Raynaud's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
-
Figure Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
-
Table Global α1-adrenoreceptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global α1-adrenoreceptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK α1-adrenoreceptor Antagonists Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb α1-adrenoreceptor Antagonists Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck α1-adrenoreceptor Antagonists Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly α1-adrenoreceptor Antagonists Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca α1-adrenoreceptor Antagonists Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer α1-adrenoreceptor Antagonists Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis α1-adrenoreceptor Antagonists Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson α1-adrenoreceptor Antagonists Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi α1-adrenoreceptor Antagonists Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer α1-adrenoreceptor Antagonists Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical α1-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical α1-adrenoreceptor Antagonists Product and Service
-
